Investigation of frequency and typing of human papillomavirus among genital warts using a reverse dot blot hybridization approach - BMC Infectious Diseases - BMC Infectious Diseases
Boda D, Neagu M, Constantin C, Voinescu RN, Caruntu C, Zurac S, et al. HPV strain distribution in patients with genital warts in a female population sample. Oncol Lett. 2016;12(3):1779–82.
Ozaydin-Yavuz G, Bilgili SG, Guducuoglu H, Yavuz IH, Elibuyuk-Aksac S, Karadag AS. Determinants of high-risk human papillomavirus infection in anogenital warts. Postepy Dermatol Alergol. 2019;36(1):76–81.
Al-Awadhi R, Al-Mutairi N, Albatineh AN, Chehadeh W. Association of HPV genotypes with external anogenital warts: a cross sectional study. BMC Infect Dis. 2019;19(1):375.
Modesitt SC, van Nagell Jr JR. The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 2005;60(10):683–92.
Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191–203.
Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57(1):43–66.
Schiffman M, Kjaer SK. Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia. JNCi monographs. 2003;2003(31):14–9.
Smith JS, Backes DM, Hoots BE, Kurman RJ, Pimenta JM. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol. 2009;113(4):917–24.
Srodon M, Stoler MH, Baber GB, Kurman RJ. The distribution of low and high-risk HPV types in vulvar and vaginal intraepithelial neoplasia (VIN and VaIN). Am J Surg Pathol. 2006;30(12):1513–8.
Javanmard D, Behravan M, Ghannadkafi M, Salehabadi A, Ziaee M, Namaei MH. Detection of Chlamydia trachomatis in pap smear samples from South Khorasan Province of Iran. Int J Fertil Steril. 2018;12(1):31.
Roberts CC, Tadesse AS, Sands J, Halvorsen T, Schofield TL, Dalen A, et al. Detection of HPV in Norwegian cervical biopsy specimens with type-specific PCR and reverse line blot assays. J Clin Virol. 2006;36(4):277–82.
Abbas AK, Aster JC. Robbins basic pathology. Amsterdam: Elsevier/Saunders; 2013.
Narisawa-Saito M, Kiyono T. Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci. 2007;98(10):1505–11.
Zare Mahmoud Abadi R, Saghafi S, Mohajertehran F, Rafiee S, Shokri M. Detection of Human Papillomavirus (HPV) in ameloblastoma using the polymerase chain reaction (PCR). J Mashhad Dent Sch. 2018;42(4):298–306.
Gravitt P, Peyton C, Alessi T, Wheeler C, Coutlee F, Hildesheim A, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38(1):357–61.
Serrano B, Alemany L, Tous S, Bruni L, Clifford GM, Weiss T, et al. Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease. Infect Agents Cancer. 2012;7(1):1–13.
Niya MHK, Tameshkel FS, Panahi M, Salim FB, Monavari SHR, Keyvani H. Human papillomavirus investigation in head and neck squamous cell carcinoma: initial report from the low risk HPV types associations. Asian Pac J Cancer Prev. 2017;18(9):2573.
Curado M-P, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, vol. IX. Lyon: IARC Press, International Agency for Research on Cancer; 2007.
Ferlay J. Cancer incidence, mortality and prevalence worldwide. GLOBOCAN2002. 2004.
Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009;360(14):1385–94.
Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low-and middle-income developing countries. Bull World Health Organ. 2001;79:954–62.
Haedicke J, Iftner T. Human papillomaviruses and cancer. Radiother Oncol. 2013;108(3):397–402.
van der Aa MA, Pukkala E, Coebergh JWW, Anttila A, Siesling S. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. Int J Cancer. 2008;122(8):1854–8.
Sasagawa T, Maehama T, Osaka Y, Sakamoto J, Shibata T, Fujita S, et al. Comparison of the digene hybrid capture 2 and Roche cobas 4800 HPV tests for detection of CIN2+ in a referral population in Japan. J Med Virol. 2018;90(5):972–80.
Chang L, Ci P, Shi J, Zhai K, Feng X, Colombara D, et al. Distribution of genital wart human papillomavirus genotypes in China: a multi-center study. J Med Virol. 2013;85(10):1765–74.
Jaberipour M, Momtahan M, Najib F, Amooei S, Saidifard F, Ghaderi A, et al. Detection of high-risk human papillomavirus types 16 and 18 but not 33 and 52 in external genital warts from Iranian females. Asian Pac J Cancer Prev. 2011;12(3):771–4.
Manyere N, Dube Mandishora R, Magwali T, Mtisi F, Mataruka K, Mtede B, et al. Human papillomavirus genotype distribution in genital warts among women in Harare-Zimbabwe. J Obstet Gynaecol. 2020;40(6):830–6.
Mehri M, Hosseinzadeh Kakroudi S, Askari FS, Mohebbi A, Tabarraei A. Prevalence of human papillomavirus genotypes in patients with genital warts in Gorgan. Iran J Clin Basic Res. 2020;4(3):3–9.
Ebrahimi A, Moradi MR, Rezaei M, Kavoussi H, Madani SH, Mohammadamini K, et al. Comparison of the risk factors and HPV types in males with anogenital warts with and without involvement of the urethral meatus in Western Iran. Acta Dermatovenerol Alpina, Pannonica et Adriatica. 2017;26(3):55–8.
Jamshidi M, Shekari M, Nejatizadeh AA, Malekzadeh K, Baghershiroodi M, Davudian P, et al. The impact of human papillomavirus (HPV) types 6, 11 in women with genital warts. Arch Gynecol Obstet. 2012;286(5):1261–7.
Moossavi M, Fereidouni M, Zardast M, Khazaei Z, Ghanbarzadeh N. Genotype distribution of human papilloma virus among women with genital warts biopsies in southern Khorasan, eastern Iran. Meta Gene. 2020;25:100720.
Yaghoobi R, Makvandi M, Afshar N, Pazyar N, Hamidifard M, Sharifpour C. High frequency of human papillomavirus genotype 16 among patients with anogenital warts. Jundishapur J Microbiol. 2015;8(11):e25882-e.
Salehi-Vaziri M, Sadeghi F, Hashemi FS, Haeri H, Bokharaei-Salim F, Monavari SH, et al. Distribution of human papillomavirus genotypes in Iranian women according to the severity of the cervical lesion. Iran Red Crescent Med J. 2016;18(4):e24458-e.
Kiwerska K, Jozefiak A, Markowska J, Kedzia W, Jackowska J, Wierzbicka M. Oral-genital human papillomavirus infection in Polish couples: frequent detection of HPV 42. BMC Infect Dis. 2019;19(1):122.
Hamkar R, Azad TM, Mahmoodi M, Seyedirashti S, Severini A, Nategh R. Prevalence of human papillomavirus in Mazandaran province, Islamic Republic of Iran. EMHJ-East Mediterr Health J. 2002;8(6):805–11.
Chalabiani S, Nazari MK, Shabani M, Davoodi NR, Sarafnejad A, Amirzargar AA. Retrospective analysis of prevalence of high-risk and low-risk Human Papillomavirus (HPV) genotypes in iranian women during 2013–2016. Asian Pac J Cancer Biol. 2017;2(4):85–90.
Yanofsky VR, Patel RV, Goldenberg G. Genital warts: a comprehensive review. J Clin Aesthet Dermatol. 2012;5(6):25–36.
Nasseri S, Monavari SH, Keyvani H, Nikkhoo B, Vahabpour Roudsari R, Khazeni M. The prevalence of Human Papilloma Virus (HPV) infection in the oligospermic and azoospermic men. Med J Islam Repub Iran. 2015;29:272.
Pujari R, Newman MR, Talia KL, Pendlebury A, Hawkes D, Ireland-Jenkin K, et al. Seborrheic keratosis-like lesion of the cervix: first report of the cytological features of a low-risk HPV 42-associated lesion. Acta Cytol. 2021;65(5):448–52.
Chen C-J, Viscidi RP, Chuang C-H, Huang Y-C, Chiu C-H, Lin T-Y. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination. J Clin Virol. 2007;38(2):126–30.
Newall AT, Brotherton JM, Quinn HE, McIntyre PB, Backhouse J, Gilbert L, et al. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia. Clin Infect Dis. 2008;46(11):1647–55.
Mohammadpour F, Mansouri A, Hadjibabaie M. Utilization evaluation of human papilloma virus vaccine (GARDASIL®) in Iran; a cross-sectional study. Iran J Pharm Res IJPR. 2020;19(1):68.
Clavero O, McCloskey J, Molina VM, Quirós B, Bravo IG, de Sanjosé S, et al. Squamous intraepithelial lesions of the anal squamocolumnar junction: histopathological classification and HPV genotyping. Papillomavirus Res. 2017;3:11–7.
Comments
Post a Comment